• Equus Total Return received an NYSE deficiency notice on Oct. 6 for failing the $1.00 minimum average share price rule.
• Non-compliance triggered by an average closing price below $1.00 over a consecutive 30-trading-day period.
• Listing remains intact during a six-month cure period, subject to meeting other NYSE continued listing standards.
• Company plans to tell the NYSE by Oct. 20 it intends to regain compliance, potentially including a reverse stock split.
• Compliance can be restored if month-end closing price reaches at least $1.00 and the 30-day average also exceeds $1.00.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Equus Total Return Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610131658PRIMZONEFULLFEED9845078) on October 13, 2026, and is solely responsible for the information contained therein.